Lineage Cell Therapeutics Inc (LCTX)

[bobby2loaves]

AgeX Share Breakdown

This is all changing minute-by-minute -- my analysis this morning is already toast!

As I understand it.........BTX currently has 28.8mm shares of AGE. 14.4mm just got sold to Juvenescence. 12.7mm are getting spun off to BTX shareholders. BTX will be left with 1.7mm shares. So absolutely yes, BTX will hold very little AGE shares in the near future. But the 2 companies will still have lots of projects where they will be working together. And now BTX is going to have plenty of cash to keep things moving from its end (cell production facilities perhaps?).

And interestingly....as part of the Juvenescence payment, BTX will get $21mm in cash, and a $21mm note they can redeem for cash in 2 years (with interest) or use to convert to Juvenescence stock after they go public!